The Japan Times - US abortion ruling threatens access to arthritis drug

EUR -
AED 4.356047
AFN 77.098481
ALL 96.578527
AMD 452.626632
ANG 2.123261
AOA 1087.678352
ARS 1715.600908
AUD 1.704695
AWG 2.137993
AZN 1.999161
BAM 1.954172
BBD 2.404706
BDT 145.89842
BGN 1.991946
BHD 0.447184
BIF 3537.212006
BMD 1.186127
BND 1.512065
BOB 8.250125
BRL 6.229061
BSD 1.193769
BTN 109.639559
BWP 15.620206
BYN 3.400581
BYR 23248.08086
BZD 2.401209
CAD 1.617438
CDF 2686.576759
CHF 0.919966
CLF 0.026042
CLP 1028.620629
CNY 8.245655
CNH 8.233
COP 4365.432106
CRC 591.217294
CUC 1.186127
CUP 31.432354
CVE 110.173654
CZK 24.292224
DJF 212.603729
DKK 7.469413
DOP 75.168628
DZD 153.797369
EGP 55.865719
ERN 17.791899
ETB 185.472969
FJD 2.643523
FKP 0.865581
GBP 0.865748
GEL 3.196593
GGP 0.865581
GHS 13.079156
GIP 0.865581
GMD 86.586829
GNF 10476.446395
GTQ 9.157446
GYD 249.783955
HKD 9.263957
HNL 31.513271
HRK 7.530128
HTG 156.252426
HUF 380.977331
IDR 19896.087161
ILS 3.678244
IMP 0.865581
INR 108.546592
IQD 1564.096604
IRR 49965.582138
ISK 145.003895
JEP 0.865581
JMD 187.097242
JOD 0.840975
JPY 183.613613
KES 153.010627
KGS 103.726642
KHR 4801.080108
KMF 492.242217
KPW 1067.513917
KRW 1719.521766
KWD 0.364259
KYD 0.994962
KZT 600.464557
LAK 25693.805403
LBP 106915.75543
LKR 369.223874
LRD 215.202481
LSL 18.957162
LTL 3.502324
LVL 0.717476
LYD 7.491789
MAD 10.829975
MDL 20.081435
MGA 5335.576238
MKD 61.632744
MMK 2490.84975
MNT 4228.096728
MOP 9.600999
MRU 47.638105
MUR 54.146602
MVR 18.337513
MWK 2070.283514
MXN 20.610384
MYR 4.675664
MZN 75.627679
NAD 18.956843
NGN 1655.726718
NIO 43.93413
NOK 11.465076
NPR 175.424773
NZD 1.97085
OMR 0.455869
PAB 1.193905
PEN 3.991774
PGK 5.110849
PHP 69.833205
PKR 333.990265
PLN 4.218222
PYG 7997.369327
QAR 4.352991
RON 5.095554
RSD 117.395701
RUB 90.860355
RWF 1741.992418
SAR 4.448418
SBD 9.550233
SCR 17.126513
SDG 713.488038
SEK 10.583212
SGD 1.506975
SHP 0.889902
SLE 28.852557
SLL 24872.480335
SOS 682.342894
SRD 45.132709
STD 24550.425312
STN 24.480116
SVC 10.446207
SYP 13118.055685
SZL 18.949053
THB 37.482821
TJS 11.145306
TMT 4.151443
TND 3.430356
TOP 2.855908
TRY 51.566909
TTD 8.106279
TWD 37.45728
TZS 3061.380922
UAH 51.171573
UGX 4268.46099
USD 1.186127
UYU 46.331976
UZS 14595.836966
VES 410.330299
VND 30863.013469
VUV 141.334941
WST 3.215329
XAF 655.427395
XAG 0.014439
XAU 0.00025
XCD 3.205566
XCG 2.151707
XDR 0.815124
XOF 655.413592
XPF 119.331742
YER 282.683658
ZAR 18.992887
ZMK 10676.554577
ZMW 23.430574
ZWL 381.932273
  • SCS

    0.0200

    16.14

    +0.12%

  • CMSC

    0.0500

    23.76

    +0.21%

  • RIO

    -4.1000

    91.03

    -4.5%

  • RBGPF

    1.3800

    83.78

    +1.65%

  • BCE

    0.3700

    25.86

    +1.43%

  • NGG

    0.2000

    85.27

    +0.23%

  • CMSD

    -0.0400

    24.05

    -0.17%

  • BCC

    0.5100

    80.81

    +0.63%

  • BTI

    0.4600

    60.68

    +0.76%

  • GSK

    0.9400

    51.6

    +1.82%

  • RELX

    -0.3700

    35.8

    -1.03%

  • BP

    -0.1600

    37.88

    -0.42%

  • JRI

    0.1400

    13.08

    +1.07%

  • RYCEF

    -0.4300

    16

    -2.69%

  • AZN

    0.1800

    92.77

    +0.19%

  • VOD

    -0.0600

    14.65

    -0.41%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: Andy Buchanan - POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

M.Fujitav--JT